Polypeptide Oxytocin Acetate Human Growth Peptides 98% Human Growth Peptides Oxytocin Acetate 50-56-6 White Powder
CAS 50-56-6 Oxytocin Acetate
Product Name:Oxytocin Acetate
Alias:Atonin,Endopituirina,Orasthin,Oxytocinum,Partocon,Pitocin,Piton,Pitupartin,Utedrin,Uteracon
Cas No.: 50-56-6
EINECS : 200-048-4
Molecular Formula: C43H66N12O12S2
Molecular Weight: 1007.19
Purity (HPLC): 98.0%min.
Appearance: White powder
Single Impurity (HPLC): 1.0%max
Amino Acid Composition: ±10% of theoretical
Peptide Content (N%): >80.0%
Water Content(Karl Fischer): <6.0%
Acetate Content(HPIC): <12.0%
MS(ESI): Consistent
Mass Balance: 95.0~105.0%
Grade : Pharmaceutical Grade
Storage: Closed, below 2 ~ 8℃ preservation
Usage : For induction of labor, postpartum oxytocin, and abortion due to uterine atony or retraction caused by the bad uterus bleeding; understand the placental function reserve (oxytocin challenge test); nasal drops can promote milk ejection.
Oxytocin (Oxt) is a mammalian neurohypophysial hormone. Produced by the hypothalamus and stored and secreted by the posterior pituitary gland, oxytocin acts primarily as a neuromodulator in the brain.
Oxytocin plays an important role in the neuroanatomy of intimacy, specifically in sexual reproduction of both sexes, in particular during and after childbirth; its name, meaning "swift childbirth", comes from Greek, oksys "swift" and , tokos "birth." It is released in large amounts after distension of the cervix and uterus during labor, facilitating birth, maternal bonding, and, after stimulation of the nipples, lactation. Both childbirth and milk ejection result from positive feedback mechanisms.
Application:
Injected oxytocin analogues are used for labor induction and to support labor in case of difficult parturition. It has largely replaced ergometrine as the principal agent to increase uterine tone in acute postpartum hemorrhage. Oxytocin is also used in veterinary medicine to facilitate birth and to stimulate milk release. The tocolyticagent atosiban (Tractocile) acts as an antagonist of oxytocin receptors; this drug is registered in many countries to suppress premature labor between 24 and 33 weeks of gestation. It has fewer side effects than drugs previously used for this purpose (ritodrine, salbutamol, and terbutaline).
Usage and dosage:
Odinopoeia or oxytocin intravenous drip, once the 2.5 - 5 units, with Sodium Chloride Injection diluted to each 1ml contains 0.01 units. Intravenous drip of the beginning of every minute of not more than 0.001 to 0.002 units, each 15 - 30 minutes increased 0.001 to 0.002 units, to achieve the contractions and normal childbirth is similar, the fastest per minute of not more than 0.02 units, usually 0.002 to 0.005 units per minute.
Control postpartum hemorrhage per minute intravenous drip of 0.02 - 0.04 units, expulsion of the placenta after intramuscular injection of 5 to 10 units.
Lactogenic just before a 2 - 3 minutes, with nasal drops a 3 drop, drop into one side or both sides of the nostril.
Preparation and specification : oxytocin injection (1) 0.5ml:2.5 units (2) 1ml:5 (3) 1ml units 10 units;
Oxytocin nasal drops 1ml:40 units. The induction of labor or prenatal uterine atony: in 2.5-5 units in 500ml 5% glucose for intravenous drip slowly (10-30 drops / minute), maximum time 20 units. (2). Prevention of postpartum hemorrhage: intramuscular injection of 5-10 on each unit, or 5% glucose solution for intravenous drip.
The main contraindication, heart disease, a caesarean history and more than three fetal maternal disable.
The COA of Oxytocin:
Certificate of Analysis for Oxytocin EP7 standard : | |||
Name of P roduct: |
Oxytocin Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 |
||
Batch No: | 120202 | Analyzed on: | 2012-2-29 |
Date of Manufacture: | 2012-2-20 | Quantity: | 30g |
CAS No.: | [50-56-6] | Expiry Date: | 2014-2-19 |
TEST | SPECIFICATION | RESULTS | |
1. Characteristic | White or almost white powder. | White powder | |
2. Identification A. HPLC |
Retention time conforms to that of the reference standard |
Conforms | |
B. Amino acids |
Asp: 0.90-1.10;Glu: 0.90-1.10 Pro: 0.90-1.10;Gly: 0.90-1.10 Leu: 0.90-1.10;Tyr: 0.7-1.05 Half-Cys: 1.4-2.1;Ile: 0.90-1.10 |
Conforms | |
3. pH | 3.0-6.0 | 5.0 | |
4. Related substances (HPLC) | Impurity A≤1.5% | 0.15% | |
Impurity B≤1.5% | 0.20% | ||
Impurity C≤1.5% | Not Detected | ||
Other single impurity≤0.5% | 0.13% | ||
Total impurities≤5.0% | 0.7% | ||
5. Acetic acid (HPLC) | 6.0%-10.0% | 7.1% | |
6. Water(KF) | NMT 5.0% | 1.4% | |
7. Bacterial endotoxins | Less than 300 IU/mg | Conforms | |
8. AcN(GC) | Not more than 0.041% | Conforms | |
9. MeOH(GC) | Not more than 0.3% | Conforms | |
10. Triethylamine(GC) | Not more than 0.032% | Conforms | |
11. Assay Calculated with reference to anhydrous, acetic acid free substance |
93.0%-102.0% |
98.8% | |
on powder | NLT 80.0 % | 90.4% | |
NLT 480 IU/mg | 542IU/mg |
More Products
Product Name | CAS No. | Specification |
AOD-9604 | CAS 221231-10-3 | 2mg/vial |
CJC-1295DAC | 2mg/vial | |
CJC-1295 | CAS 863288-34-0 | 2mg/vial |
Deslorelin | CAS 57773-65-6 | 20mg/vial |
DSIP | CAS 62568-57-4 | 2mg/vial |
Epitalon | CAS 307297-39-8 | 10mg/vial |
Follistatin 344 | 1mg/vial | |
GDF-8 | 1mg/vial | |
GHRP-2 | CAS 158861-67-7 | 5mg/vial |
10mg/vial | ||
GHRP-6 | CAS 87616-84-0 | 5mg/vial |
10mg/vial | ||
Gonadorelin | CAS 34973-08-5 | 2mg/vial |
Hexarelin | CAS 140703-51-1 | 2mg/vial |
Ipamorelin | CAS 170851-70-4 | 2mg/vial |
5mg/vial | ||
Melanotan I | CAS 75921-69-6 | 10mg/vial |
Melanotan II | CAS 121062-08-6 | 10mg/vial |
MGF | 2mg/vial | |
5mg/vial | ||
PEG-MGF | 2mg/vial | |
Pentadecapeptide BPC 157 | 2mg/vial | |
PT141 | CAS 189691-06-3 | 10mg/vial |
Selank | 5mg/vial | |
Sermorelin | CAS 86168-78-7 | 2mg/vial |
TB500 | CAS 75591-33-4 | 2mg/vial |
5mg/vial | ||
Tesamorelin | CAS 218949-48-5 | 2mg/vial |
Triptorelin Acetate | CAS 57773-63-4 | 2mg/vial |
If you are interested inTrestolone,please contact:
Whatsapp:+86 15372415908